Bladder drug may unlock better blood flow for older women
NCT ID NCT07674680
First seen Jun 29, 2026 · Last updated Jul 29, 2026 · Updated 3 times
Summary
This early study tests whether a drug called gemtesa (used for overactive bladder) can improve blood vessel function in women aged 18 to 70. Researchers want to see if targeting beta3 receptors in blood vessels can help them relax and improve blood flow. The trial involves 60 healthy women and uses ultrasound to measure changes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- gemtesa (vibegron)
- What this could lead to
- If beta3 receptors are found to help blood vessels work better, this could point toward new treatments for age-related heart issues in women.
- What could go wrong
- This is a very early, small study (60 people) testing a drug already approved for other uses. It may not show clear benefits or apply to all women.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AGING are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Missouri
Columbia, Missouri, 65211, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could your heart hold the key to Alzheimer's prevention?
- Gut bacteria may soothe menopause symptoms — a trial puts it to the test
- The aging Body's hidden water shift: a new study investigates
- A Pillow-Side herbal sachet: a natural sleep aid for menopause?
- Implant vs. gel: which hormone delivery wins for menopause?
- Mushroom blend may tame menopause symptoms — trial puts it to the test